Araris Biotech supported with CHF 2.5M Swiss accelerator grant from Innosuisse to develop antibody-drug conjugate candidates
The Swiss Accelerator programme’s total funding grant amounted to CHF 112M (~$125 million) with support per project amounting to a...
Read moreDetails